Biosimilar Market Research Reports


Global Biosimilars Industry Report 2015

By QYResearch Group
"...... ional markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Biosimilars industry i......"

Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application (Oncology, Blood Disorders) - Global Forecast to 2020

By MarketsandMarkets
"...... wing aging population. Biosimilars are similar versions of their corresponding patented biologic drugs, and are similar with regards to their quality, safety, and efficacy. The global biosimilars market is estimated to be worth $2.29 billion in 2015,......"

BIOSIMILARS - Regulatory Framework and Pipeline Analysis

By CBR Pharma Insights
"...... re spending substantially. All the countries are focusing on reducing the healthcare expenditure and biosimilars compliments to this goal. Biologic products are complex in structure and follow a complex manufacturing process thus, some variation exis......"

2015 Deep Research Report on Global Biologics and Biosimilars Industry

By QYResearch Group
"...... and news analysis, etc. For international and China market analysis, the report analyzes Biologics and Biosimilars markets in China and other countries or regions (such as Asia, Europe, North America etc) by presenting research on global products......"

New Phase of Mab biosimilar knocks the door Biosimilar Oppurtunities In Japan

By MP Advisors
"...... hing various benefits for GE use at Pharmacy, hospital level) – now in 2014, Generic penetration of small molecules is changing the trend line and moving towards faster market penetration. While for biosimilars since their launch from 2009- various J......"

Global Oncology Biosimilars Market 2014-2018

By Infiniti Research Limited
"...... the innovator product, they are not an exact copy of the reference biopharmaceutical product. Currently, biosimilars are being incorporated into oncology treatment practices. The biosimilars used in oncology in the supportive care setting are known ......"

Biosimilars - Biosimilars on the cusp of a new era

By CBR Pharma Insights
"...... proval of biosimilars, but there is still a lack of consistency, particularly between the two leading agencies the FDA and EMA. Moreover, there are some concerns around biosimilar use, for example with physicians worried about how similar certain ......"

PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market

By GlobalData
"...... describes the operations strategy of these companies. Furthermore, it includes a geographical segmentation of various markets including the EU and US, as well as emerging markets such as India providing in-depth analysis of these markets' regulatory......"

Therapeutic Class Overview : Emergence Of Biogenerics Era In Japan - It's Time to Welcome Antibody Biosimilars of Foreign Origins Soon

By MP Advisors
"...... – 1.) it will open antibody biosimilar market in Japan, and 2.) the approval will be based largely from overseas data. ~ ¥200b worth of biologic products is going off patent by 2015 and this value exceeds ~ ¥400b if we include products that will s......"

Global Biosimilars Market 2014-2018

By Infiniti Research Limited
"...... of biosimilar manufacturing. However, the risks related to drug failure could pose a challenge to the growth of this market. TechNavio's report, the Global Biosimilars Market 2014-2018, has been prepared based on an in-depth market analysis with i......"